{"name":"R3 Medical Research","slug":"r3-medical-research","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNTjN4ZVdKZ0FzQ1V5MnIxa21wRzJzVUZ0UlMwR0JmZDRhNlFTSW1QQ05fYnZLVkxuTTA4RHpVRy1ydG1OU1VLVHNtRWhDb3R1M1llQWZFS0dwT0EzYkI4dDc3N0VFZ1lrT0JYNkFtUXdQa055cHdfLTNVaXVnXzN1a3pycW1oY2g1Vk81bVVueWotOURndGpieG9HZV81cTk3SHNrM2d5Rmh1ZW5acjd0cklnM0FHcnltTlhkTUk5Y3p1YnpLNW03bVRlMmd5Wm96NG44MmQtbTNXRGVyNF94TFB0c256VC1ncHhQR29YemM0ZnJsSmdr?oc=5","date":"2026-04-02","type":"regulatory","source":"Business Wire","summary":"CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline - Business Wire","headline":"CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVUJnWHkzMzRpMGVVX09QREhUcUVGTHJFaFpERDFLZ1JaM0hYbFIwTW1xM0NpQWg5WWhVSTM4RkFKZnFfeTRBMVR2bVlMZ2JDR19ZS0Rqb0d0VVJFQ2dUZlluZnZnR1MxbllEY056c1RFRm1fVktLV3drbFY0ZVZHRTI3dTdVdlZDSU1DMXVHMjhKUk51ckJuUVM5djJGcXhWby1qcWtyVVMtZFFFRFdmQVRtWml1WTNE?oc=5","date":"2026-03-24","type":"earnings","source":"Clinical Leader","summary":"A Clinical Machine Learning Operations (MLOps) Maturity Framework For Biopharma - Clinical Leader","headline":"A Clinical Machine Learning Operations (MLOps) Maturity Framework For Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNZWtZVDJwRXhVN0c0cHM2Y2RGaFBwbEhCYzZYTC1wZ3JvbjJqNEN6dkhRMUtvQUZIMUVGeFQzdkp4OHJCdEM4LXN2a3JEV0pkRkZ6TlBXRXZ1T1dVRnMwMG9qUFg2VTBsXzNweGdyTEFfUnJ6VVpCOUhreUJtOHpITGtDamF0VFE4X3dzaTgtMzZTa21ibGdxWUFKb3dxLTdVRWU0SEZtZ0QwT0NqRGtIbUZRbkdnUXBjLVFuUVdyWEo4ZlRqWXhr?oc=5","date":"2026-02-13","type":"trial","source":"The Clinical Trial Vanguard","summary":"Why Big Pharma Clinical Trial Digital Transformation Initiatives Fail - The Clinical Trial Vanguard","headline":"Why Big Pharma Clinical Trial Digital Transformation Initiatives Fail","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBRNjR5R3Y3MVFuN0pnYnJHMk1GalBTMmFFWmxEaWpLLWRpQnJWTEkydGM5alRVMVJZeVVWMU02cVFTZmlxdi1FX0JhdWIzenExb0RTRTF4dFJjQXpoajJGNUdFMnlycVNEcGt6SzJMYjZybU83dlQyX1FkdEItZw?oc=5","date":"2026-02-03","type":"pipeline","source":"pharmaphorum","summary":"Navigating the new ICH E6 (R3): Key changes for sponsors - pharmaphorum","headline":"Navigating the new ICH E6 (R3): Key changes for sponsors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPdjVzeVJOX2RvMmZ2N1lzWUlMWEhJeUh6bzFybnllaVZMUjR0aGNhRTdtaVJQckVDTUpuQTlhVGg0VDNlUUJMeXhESzRtdGFkdFdLWFkwX0VRTGtQM2FLckZHa1hUMThya2VqQUxDYkRZa2gxVUJaYW42Z2tJanp5TzVOZ1V4RHB5TEZwYzRsQmozZklXWXlnME0zZUQyNndHZmxMX0JjVUZ4dzF0WUUtNkJLVVZCOEVJSV9zcXdlTlQwUi1jWGduclZGR212cWptWElCd2htVW9PMFlLOHRKdW9xWHVITjRJLXdRZ1JabU9kSHN0cGdQSHBoTHVjTE93U0E5bTZuZWxncTBtLWdnNg?oc=5","date":"2026-01-29","type":"regulatory","source":"VWV","summary":"Supporting innovation, increasing transparency and prioritising efficiency - what to expect from the UK's new clinical trials regulatory framework - VWV","headline":"Supporting innovation, increasing transparency and prioritising efficiency - what to expect from the UK's new clinical t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQc2RoZnI3dnBBTWVBMklGMm4zMkI0Rmt2S2VRb1F5bXRxOEh0NFZ3eU5oX1FBNE5oNThURXhfLUZCVkF0dXY5SENxcHZBV2FOSV9hdTdpeXRNVUxfN1N3VEc5dXQzT0ZOcUFoY05NcGlfNXVzbkpiSTBnTjR6emxLSUVpSFdPVnhlV1llakk5c01CZi1hLTJTa2FXUjRWRnY3?oc=5","date":"2026-01-16","type":"pipeline","source":"the-scientist.com","summary":"Aging Research Takes the Spotlight During JPM Week at the 2026 Biotech Showcase - the-scientist.com","headline":"Aging Research Takes the Spotlight During JPM Week at the 2026 Biotech Showcase - the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPS3ZrbS1fbzlVQ0VjUFZFUjllNVJQdGhBVVQwWVlSVDUydVdXMl9jRzdFTmFYVUpYN2p3QmFvWlRJNGJTSFVwS1VtbnR0THRFV3lpdmhIVE1lb3lHMkxoTDAyb0FXRVhGZ1lRZTg1ejR6REJZMWp2RzByY3ZkZ0l2R2J0c2M2cW5SSVRTcFM1RzM5NzFHand6SkZ6NHlkSHh6RE5fQlBXd1R5OFZTajRjWC1iSkNSZExNQzBMR0p1THlteXdyTmRrdEk3YjluQTR6UTY2RnFn?oc=5","date":"2025-10-08","type":"pipeline","source":"The Malaysian Reserve","summary":"ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks - The Malaysian Reserve","headline":"ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPS3VtZE1yYVZ1SmoyYS1KVTVqZkFFRm5BZWdmN1liYk5tYnhOQWc3Wk9EelBYX2VmM21TZmU3T0dLSjJNLXBBcFFlX0xGUDJQYmtob3ZtYXZrV3Vra1dtU20tRmNLTzJBMjl0ZFNjeWdtXzZWMWNzMGQ2NmFNOVc5NDdPb3VrT0MwcVE?oc=5","date":"2025-10-03","type":"pipeline","source":"The Medicine Maker","summary":"A Toolkit for ICH-E6(R3) - The Medicine Maker","headline":"A Toolkit for ICH-E6(R3)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNbkJHZGExcHEzT2JCVEl3eGxpN3lzX3RVYzRzRGlXa3BSMVVOQWxGeEN6c1RYWlNGWjQ1a2pSR1Q2Y2RyY0h2a0dMRk5FWHJzaFZCYW1wWjNfeW00RDRpQm5vdjdpOXUxM181MEMzbmRXY1FCZ2ozblg2UFZocjh1VVljU1RadzA5bXp3Mms3akVVTGhQTzlSY2o0SHc0R3hrRENj?oc=5","date":"2025-09-18","type":"trial","source":"Clinical Leader","summary":"ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials - Clinical Leader","headline":"ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQWXk1LW5ZNEp2TUt2QWpPTnRmaC1BdFcwSDNfMG1VSjNQSE5JTTV4UnZVd2RIWkMxVk9LZ0FKbGtkTHhGcFFOMGttLVc4V3JrVnBjbnF5YkpvWXg2dmo2YlRHMTZDY3F6a012MWJiNzAtbW9zOUlTNWFpU2hGVjdpTGlsX01YLVl1dC1YMWFCcEFvS1QyUk1fWEJB?oc=5","date":"2025-07-24","type":"trial","source":"Pharmaceutical Technology","summary":"How ICH E6 (R3) is changing clinical trials - Pharmaceutical Technology","headline":"How ICH E6 (R3) is changing clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOekkzNGg3SzRCMVYtUXB3QWh3aGROejBMWFcxeWVyQmJqSzZPRGlYUjFSYmJwa1BBUzI3WHYxSXJsMXc2TnJpOElfbWdGWTBjWUtKT2ptbGdVSTJWeWJIN0tQTTViQ1dxYUNxcWREeXZBRllJLUwtX3RYczVCNHJNZnRZOVY4NzNiLTFUUk50eElsNVRKVnMtX0RFUEt1ejhDZ0xCN3pBbHdWX1JGQm5kdjZR?oc=5","date":"2025-07-21","type":"pipeline","source":"Syneos Health","summary":"Why Early Patient Advocacy Matters: What Pharma Can Learn from Brand Loyalty - Syneos Health","headline":"Why Early Patient Advocacy Matters: What Pharma Can Learn from Brand Loyalty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNb0dFc0dKdVFDX0FjUnJ2LUdhSGFOX01QSU9RTk1od3RKVXpacUtOZFNZOTBWN0RtM0Q2Mm1pXzBHZkYyQkVjWjBDeE55SGt4NjYwZmJRWkJjdzVuSHludGNibDlfZ2xXcnJ5YmZMSzg0V1hLc1VLbEZ4Q08tQ3o1T3I0bjVnaC0ya0V4aFU0cU44bXRuTmZCR0x5a2tYbHBxazNwT1ZDdTBtdGo3N0N1QlhCR2JRUmZqdWc2OGx3NF9jM0ZOQVZIQUhwTFhFYWowcVdIOF9DOGVfTmZXOUF4Q3pTWnR5em11azFXZFpUVUZ3WWNEWjl4TVkxZTBDdw?oc=5","date":"2025-03-03","type":"pipeline","source":"PR Newswire","summary":"TransCelerate BioPharma Publishes Resources to Accelerate Industry Adoption of Newly-Released ICH E6(R3) Guidelines - PR Newswire","headline":"TransCelerate BioPharma Publishes Resources to Accelerate Industry Adoption of Newly-Released ICH E6(R3) Guidelines","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}